Cleared Traditional

ROTOR-GENE Q MDX

K113319 · QIAGEN GmbH · Microbiology

Feb 2012

Decision

88d

Days

Class 2

Risk

About This 510(k) Submission

K113319 is an FDA 510(k) clearance for the ROTOR-GENE Q MDX, a Real Time Nucleic Acid Amplification System (Class II — Special Controls, product code OOI), submitted by QIAGEN GmbH (Gaithersburg, US). The FDA issued a Cleared decision on February 6, 2012, 88 days after receiving the submission on November 10, 2011. This device falls under the Microbiology review panel. Regulated under 21 CFR 862.2570.

Submission Details

510(k) Number	K113319 FDA.gov
FDA Decision	Cleared SESE
Date Received	November 10, 2011
Decision Date	February 06, 2012
Days to Decision	88 days
Submission Type	Traditional
Review Panel	Microbiology (MI)
Summary	Summary PDF

Device Classification

Product Code	OOI — Real Time Nucleic Acid Amplification System
Device Class	Class II — Special Controls
CFR Regulation	21 CFR 862.2570
Definition	The System Is A Clinical Multiplex Instrument Intended To Measure And Sort Multiple Signals Generated My Multiple Probes, Intercalating Dyes, Or Other Ligands In An Assay From A Clinical Sample. Signals May Be Generated By Fluorescence Or Other Phenomena And May Be Measured Using Filters On A Photodiode Or Other Detector. It May Integrate Sample And/or Reagent Handling, Amplification, Dedicated Instrument Control, Data Acquisition Software, Raw Data Storage Mechanisms And Other Essential Hardware Components Along With The Signal Reader Unit. The System Is Used With Specific Assays To Comprise An Assay Test System.